Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
BioNexus Gene Lab Corp. - SIC # 4742 -
Ticker
Exchange
SIC #
Website
Latest Ticker
BGLC
Nasdaq
4742
www.bionexusgenelab.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for BioNexus Gene Lab Corp.
Wall Street Set to Open Lower Wednesday as Jobs Data Misses Forecasts
- Jul 2nd, 2025 7:13 am
US Futures Subdued as Investors Eye Key Employment Data
- Jul 2nd, 2025 6:29 am
BioNexus Gene Lab Corp. Regains Nasdaq Compliance, Signaling Strategic Stability and Growth Readiness
- Apr 30th, 2025 9:25 am
BioNexus Gene Lab Corp. Files 2024 Annual Report Highlighting Strategic Innovation, Operational Resilience, and Growth Trajectory
- Apr 15th, 2025 9:00 am
Bionexus Gene Lab enters partnership with ML Tech
- Mar 8th, 2025 9:10 am
BioNexus Gene Lab Leads Our Top 3 US Penny Stocks
- Dec 6th, 2024 1:07 pm
BioNexus Gene Lab Corporation announces entry into Biogas Sector via Teaming Agreement with Protech Builders Sdn. Bhd.
- Sep 25th, 2024 9:31 am
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement with VITARRAY Global Pte. Ltd.
- Sep 13th, 2024 10:05 am
BioNexus Gene Lab Corp. Signs Strategic Partnership MOU with Shenzhen Rongguang Group to Advance Cancer Screening, Precision Medicine, and Preventative Healthcare Solutions
- Sep 12th, 2024 11:23 am
BioNexus Gene Lab Corp Announces New Business Developments for Subsidiary Chemrex with Investment in High-Quality Color Paste Production
- Sep 11th, 2024 9:05 am
BioNexus Gene Lab Corp. Announces Successful Securities Commission of Malaysia (MyCIF) Co-Investment in Ascension Innovation Sdn Bhd
- Aug 27th, 2024 9:35 am
BioNexus Gene Lab Corp. Completes Strategic RM 1 Million Investment in Ascension Innovation Sdn Bhd
- Aug 26th, 2024 10:15 am
BioNexus Gene Lab Second Quarter 2024 Earnings: US$0.005 loss per share (vs US$0.018 loss in 2Q 2023)
- Aug 17th, 2024 7:37 am
Scroll